Life SciencesLiability
Get a quote

TL;DR

San Diego pairs a world-leading genomics and life-sciences base with a strong digital health and health-technology scene - digital diagnostics, remote monitoring, precision-health platforms, and AI-in-health. For these operators the software is the product, so cyber liability and technology errors and omissions are the primary product-liability vehicles, not a traditional products policy. The program also has to answer HIPAA business-associate scope, California CCPA and CPRA plus genetic-privacy provisions, and, where the software is a regulated device, a software-as-a-medical-device (SaMD) structure. Traditional products liability alone is structurally inadequate for this class.

San Diego digital health

Digital health insurance in San Diego - where software is the product and cyber is the tower.

San Diego combines one of the world's deepest genomics and life-sciences bases with a strong and growing digital health scene - digital diagnostics, remote patient monitoring, precision-health platforms, and AI-driven clinical decision support - fed by the region's genomics-informatics talent and academic medicine at UC San Diego. A digital-health operator here looks nothing like a device manufacturer or a therapeutics developer: its product is software, and the harms it can cause flow from code, algorithms, and the protected health information moving through the platform rather than from a physical article.

That distinction drives the entire program. For a digital-health company the load-bearing lines are cyber liability and technology errors and omissions, because a defect in the software, an algorithm error, or a data breach is the exposure that generates the largest claims. San Diego's genomics and precision-health crossover also means a meaningful share of local platforms function as regulated software - so the program frequently has to be built around a software-as-a-medical-device structure, HIPAA business-associate obligations, and California's layered privacy law, not around a generic products stack. This digital-health page is distinct from the San Diego genomics and diagnostics lab page, which addresses specimen-handling and clinical-lab risk.

Get a quoteRun the Free Analyzer

Last updated 2026-07-14

Cluster shape

The San Diego digital health and health-technology cluster

San Diego's digital health scene sits directly on top of its genomics and life-sciences base, and that adjacency shapes the risk. Companies here build digital diagnostics, remote patient monitoring, precision-health and consumer-genomics platforms, and AI-in-health decision support, drawing on the region's unusually deep pool of genomics-informatics and computational-biology talent. The result is a cluster where software companies routinely handle clinical-grade and genetic data rather than ordinary business records.

This vertical is distinct from San Diego's therapeutics, medical-device, and genomics-lab clusters, each of which carries its own coverage architecture on a separate page. A digital-health operator is defined by software that clinicians and patients act on, by the PHI and genetic data flowing through its platform, and by service relationships with health systems and covered entities. That combination concentrates risk in cyber and technology E&O rather than in the products-liability and clinical-trial exposures that dominate a device maker or drug developer.

Academic medicine at UC San Diego and the surrounding precision-health ecosystem give the cluster its crossover character. Many platforms straddle the line between wellness software and regulated clinical tools, and some function as software-as-a-medical-device. That regulatory ambiguity is a defining feature of the San Diego digital-health population, and an insurance program that treats these companies as generic technology firms misses the health-data and clinical-decision exposures that produce the class's largest claims.

Coverage architecture

Coverage built for software as the product

Cyber liability and technology errors and omissions are the primary product-liability vehicles for a digital-health company, because the software is the product. Cyber responds to breach and regulatory exposure tied to the PHI and genetic data on the platform, and technology E&O responds to economic loss from software defects and failure to perform. Market-typical limits for both lines are sized to the sensitivity and volume of the data and to the criticality of the software, not to headcount, and are placed on a standalone basis through A-rated specialty markets rather than folded into a small-business add-on.

HIPAA business-associate scope shapes the program. A digital-health platform that creates, receives, maintains, or transmits PHI on behalf of a covered entity is a business associate, and its business associate agreements impose specific security, breach-notification, and indemnity obligations that the cyber and technology E&O policies have to be structured to answer. Where the software meets the FDA definition of a medical device, a software-as-a-medical-device (SaMD) structure applies - common in San Diego given the genomics and precision-health crossover - and algorithm and AI decision-support liability becomes a distinct exposure, because a flawed clinical recommendation can drive a bodily-injury claim that a pure economic-loss form does not fully answer.

Underwriters in this class expect a demonstrable security posture, and SOC 2 attestation is the baseline they look for when sizing cyber and technology E&O limits and terms. California's privacy regime is covered alongside HIPAA rather than in place of it: CCPA and CPRA, together with the state's genetic-privacy provisions, apply above the federal floor and expand both the regulatory exposure and the defense and penalty scenarios the program has to contemplate. A traditional products-liability policy alone is structurally inadequate here, because it is built for physical articles and does not respond to software defect, algorithm error, or data compromise.

Regulatory + market context

HIPAA, California privacy law, and the SaMD line

Digital-health operators sit under two layers of data-privacy law. HIPAA sets the federal floor and, for a platform acting as a business associate, drives the security and breach-notification obligations its BAAs incorporate. Above that floor, California's CCPA and CPRA and the state's genetic-privacy provisions apply additional consumer-privacy and genetic-data protections, which is material in San Diego given how much of the cluster handles genetic and precision-health data. Underwriters treat both layers as live regulatory exposure and scope cyber and technology E&O accordingly.

Where a platform's software meets the FDA definition of a medical device, it is regulated as software-as-a-medical-device, and the program has to reflect that classification - a structure that is common in San Diego because of the genomics and precision-health crossover. That framing pulls algorithm and AI decision-support liability into focus and shifts the coverage conversation from a pure technology E&O footing toward a coordinated structure that also contemplates clinical harm. Building the program with A-rated specialty markets that understand SaMD, HIPAA business-associate scope, and California privacy law keeps the coverage aligned as the regulatory picture evolves.

Frequently asked

Common questions from San Diego digital health operators

Why are cyber and technology E&O the primary product-liability lines for a digital-health company?

Because the software is the product. For a digital-health operator the harms that generate the largest claims flow from software defects, algorithm error, and data compromise, not from a physical article, so a traditional products-liability policy alone is structurally inadequate. Cyber liability responds to breach and regulatory exposure tied to the PHI and genetic data on the platform, and technology errors and omissions responds to economic loss from software that fails to perform. Both are sized to data sensitivity and software criticality and placed standalone through A-rated specialty markets.

How does the San Diego genomics and precision-health crossover make a SaMD structure common?

San Diego's digital-health companies sit on top of the region's genomics and life-sciences base, so many platforms function as clinical tools rather than wellness apps, and a meaningful share meet the FDA definition of a medical device. When software is a regulated device it is treated as software-as-a-medical-device (SaMD), which is common here because of that crossover. A SaMD framing pulls algorithm and AI decision-support liability into focus, because a flawed clinical recommendation can drive a bodily-injury claim, and the program has to be structured to answer clinical harm alongside economic loss and data breach.

What HIPAA and California privacy obligations does the program have to answer?

A digital-health platform that creates, receives, maintains, or transmits PHI on behalf of a covered entity is a HIPAA business associate, and its business associate agreements impose specific security, breach-notification, and indemnity terms that the cyber and technology E&O policies must be structured to meet. On top of the HIPAA floor, California's CCPA and CPRA and the state's genetic-privacy provisions add consumer-privacy and genetic-data protections that are especially material given how much San Diego digital-health data is genetic. Both layers are covered together, expanding the regulatory and defense exposure the program has to contemplate.

What do underwriters expect from a digital-health company before writing the program?

Underwriters in this class expect a demonstrable security posture, and SOC 2 attestation is the baseline they look for when sizing cyber and technology E&O limits and terms. They also weigh whether the platform acts as a HIPAA business associate, whether the software functions as a regulated device under a software-as-a-medical-device framing, and how the company handles PHI and genetic data under HIPAA and California privacy law. A company that can evidence SOC 2 and a clear data-governance and regulatory posture is underwritten on far better terms than one that cannot.

Telehealth & digital health practice →Digital health startup insurance →San Diego biotech insurance →California state guide →

Free coverage review

A specialist will reach out by end of business day.

Programs placed through A-rated specialty markets. Send your contract, insurance schedule, or current COI - a specialist returns a clause-by-clause read by end of business day.

Get my quote

Specifically for San Diego digital health operators.

Programs placed through A-rated specialty markets. Your specialist handles unlimited certificates of insurance, annual coverage reviews, and claims advocacy.